ABOUT    |    BENEFITS    |    BACKGROUND    |    HOW IT WORKS    |    CONTACT

ABOUT    |    BENEFITS    |    BACKGROUND    |    HOW IT WORKS    |    CONTACT

ABOUT    |    BENEFITS    |    HOW IT WORKS    |   CONTACT   |   BACKGROUND

Apoll LX tm blue and red logo with strapline 'Launch Success' .
Website home icon of a house

THE FLEXIBLE APPLICATION THAT DELIVERS SMART, CLEAR AND COLLABORATIVE LAUNCH PLANNING STRATEGY

THE FLEXIBLE SOFTWARE SOLUTION FOR SMART, CLEAR AND COLLABORATIVE PHARMA LAUNCH PLANNING STRATEGY

THE FLEXIBLE SOFTWARE SOLUTION FOR SMART, CLEAR AND COLLABORATIVE PHARMA LAUNCH PLANNING STRATEGY

GALBRAITHWIGHT:

 THE EXPERTISE BEHIND APOLLO LX

Apollo LX has been developed by GalbraithWight. GalbraithWight is a team of expert practitioners with

extensive international, senior level strategic and operational experience within the global pharmaceutical

business that specializes in consulting and training solutions for the global healthcare industry.

Apollo LX has our experience and expertise in Market Access and Product Launches embedded

throughout the application.

 

ABOUT GALBRAITHWIGHT:

KEY FACTS

Founded in 1997 - 20 years successful experience

Highly experienced Consultant team in Europe, US & Asia Pacific

Offices in the UK, Italy & the USA

Extensive international Payer network

Three Centres of Excellence

Strategic Partnerships

OUR MISSION

We are proud to help healthcare companies enable patients and their carers gain rapid and maintained access to life saving and enhancing healthcare, through innovative Market Access solutions globally.

OUR CENTRES OF EXCELLENCE

 

Our three Centres of Excellence design, develop and deliver world-class consulting and training solutions globally in Brand & Launch Excellence, Market Access and Insight Market Research design.

MARKET ACCESS

GalbraithWight has a partnership approach to support your Brand Excellence and decision making needs, with actionable and practical tailored solutions.

We help our clients identify, create and communicate the optimum Market Access solution for their products, at any stage of the development and commercialisation process.

Our Insight Market Research programme arms you with the knowledge and insights to launch your new brand successfully. We help our clients answer their critical Market Access questions.

LAUNCH & BRAND EXCELLENCE

Insight Market Research

OUR LAUNCH EXPERTISE

 

Our experience spans many of the top global biotech and pharmaceutical companies including AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Merck, Novartis, Pfizer, Sanofi Pasteur MSD and Sanofi. We have worked on many notable brand launches across varied therapy areas.

WE WORK ACROSS ALL THERAPY AREAS

OUR LAUNCH EXPERTISE

 

Click here to visit our website find out more about GalbraithWight’s expertise and services.

We’d be delighted to discuss the features and benefits of Apollo LX and GalbraithWight’s with you in more detail. Please click here to contact us to find out more.

Antivirals

Atripla | Truvada | Videx | Viread | Zerit | Zovirax

Cardiovascular

Aprovel | Clexane | Eliquis | Ikorel | Lipitor | Norvasc | Plavix | Pradaxa | Zocor

Central Nervous System

Abilify | Aricept | Cymbalt | Imigran | Pristiq | Seroquel | Zyprexa

Oncology

Empliciti | Halaven | Ibrance | Lenvima | Opdivo | Revlimid | Sprycel | Taxol | Taxotere Torisel Votrient | Yervoy

Infectious Diseases

Ambisome | Dificlir | Diflucan | Mycamine | Primaxin I.V. | Sivextro | Zerbaxa | Zithromax

Rare & Orphan Diseases

ALS | Cystic Fibrosis | DMD | EPGA | Fabry Disease | NMO | Gene Therapy

Respiratory System

Beconase | Flixonase | Flixotide | Serevent | Zirtek

Vaccines

Gardasil | HBvaxPRO | Prevenar | Pneumovax23 | Rotateq | Zostavax

CONTACT US

GALBRAITHWIGHT USA OFFICE  |  148 FAIRWAY DRIVE  |  PRINCETON  |  NJ 08540  |  USA  |  WWW.GALBRAITHWIGHT.COM

COLIN WIGHT  |  CHIEF EXECUTIVE  |  C.WIGHT@GALBRAITHWIGHT.COM  |  +1-609-924-5486